Psychemedics Corp
NASDAQ:PMD
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
US |
Psychemedics Corp
NASDAQ:PMD
|
14.7m USD | -3.6 | ||
US |
Cigna Corp
NYSE:CI
|
98.5B USD | 27.2 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
91.3B EUR | 27.1 | |
US |
CVS Health Corp
NYSE:CVS
|
69B USD | 9.4 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
16B EUR | -27 | |
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
16.9B USD | 39.1 | ||
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.2B USD | 18 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.3B EUR | 22.7 | |
US |
DaVita Inc
NYSE:DVA
|
11.9B USD | 14.6 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
11B EUR | 22 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -18.6 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.